Suppression of estrogenic activity by medroxyprogesterone acetate in tamoxifen-treated patients after surgery for breast cancer to reduce the risk of endometrial cancer development

Hiroyoshi Doihara, Shigemitsu Takashima, Akira Kurita, Shosuke Moriwaki

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Suppression of estrogenic activity by medroxyprogesterone acetate in tamoxifen-treated patients after surgery for breast cancer to reduce the risk of endometrial cancer development'. Together they form a unique fingerprint.

Medicine & Life Sciences